Healthcare provider profile · identity verified

Liby Mathew, MD

Internal Medicine · PARAMUS, NJ · NPI 1154587566

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	517	153
Amlodipine Besylate	Amlodipine Besylate	356	128
Levothyroxine Sodium	Levothyroxine Sodium	315	86
Omeprazole	Omeprazole	267	81
Losartan Potassium	Losartan Potassium	244	71
Simvastatin	Simvastatin	235	66
Metformin Hcl	Metformin Hcl	210	65
Albuterol Sulfate Hfa	Albuterol Sulfate	193	84
Rosuvastatin Calcium	Rosuvastatin Calcium	190	68
Metoprolol Succinate	Metoprolol Succinate	173	55
Metformin Hcl Er	Metformin Hcl	159	54
Hydrochlorothiazide	Hydrochlorothiazide	158	49
Pantoprazole Sodium	Pantoprazole Sodium	155	49
Lisinopril	Lisinopril	135	41
Gabapentin	Gabapentin	111	41
Alprazolam	Alprazolam	102	41
Allopurinol	Allopurinol	101	32
Valsartan	Valsartan	96	32
Fluticasone Propionate	Fluticasone Propionate	92	40
Zolpidem Tartrate	Zolpidem Tartrate	91	25
Alendronate Sodium	Alendronate Sodium	88	26
Montelukast Sodium	Montelukast Sodium	86	33
Famotidine	Famotidine	84	32
Ozempic	Semaglutide	81	15
Sertraline Hcl	Sertraline Hcl	75	22
Metoprolol Tartrate	Metoprolol Tartrate	73	27
Fenofibrate	Fenofibrate Nanocrystallized	72	12
Escitalopram Oxalate	Escitalopram Oxalate	70	25
Clopidogrel	Clopidogrel Bisulfate	65	20
Pravastatin Sodium	Pravastatin Sodium	65	20
Hydralazine Hcl	Hydralazine Hcl	63	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	53
Duloxetine Hcl	Duloxetine Hcl	59	14
Ezetimibe	Ezetimibe	58	20
Furosemide	Furosemide	55	17
Nystatin	Nystatin	54	25
Tamsulosin Hcl	Tamsulosin Hcl	51	18
Synthroid	Levothyroxine Sodium	50	16
Carvedilol	Carvedilol	49	19
Eliquis	Apixaban	47	18
Potassium Chloride	Potassium Chloride	47	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Trazodone Hcl	Trazodone Hcl	44	16
Januvia	Sitagliptin Phosphate	43	12
Mirtazapine	Mirtazapine	43	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	36
Triamcinolone Acetonide	Triamcinolone Acetonide	41	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	18
Jardiance	Empagliflozin	39	suppressed
Glipizide	Glipizide	34	12
Spironolactone	Spironolactone	34	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Atenolol	Atenolol	32	13
Doxycycline Hyclate	Doxycycline Hyclate	32	23
Lorazepam	Lorazepam	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	12
Azithromycin	Azithromycin	28	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Enulose	Lactulose	25	suppressed
Finasteride	Finasteride	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Methylprednisolone	Methylprednisolone	24	21
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	15
Meloxicam	Meloxicam	23	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	11
Sucralfate	Sucralfate	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Xarelto	Rivaroxaban	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	14
Epinephrine	Epinephrine	19	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Prednisone	Prednisone	18	13
Warfarin Sodium	Warfarin Sodium	18	suppressed
Baclofen	Baclofen	17	suppressed
Cephalexin	Cephalexin	17	14
Diazepam	Diazepam	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ramipril	Ramipril	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Potassium Citrate Er	Potassium Citrate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lactulose	Lactulose	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Temazepam	Temazepam	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error